Printer Friendly
The Free Library
19,585,763 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Biovail to Present at the Scotia Capital Spring Growth Conference.


TORONTO -- Biovail Corporation (NYSE NYSE

See: New York Stock Exchange
:BVF BVF Biovail Corporation (stock symbol)
BVF Berufsverband der Frauenärzte eV (Muenchen, Germany)
BVF Bearing Versus Frequency
)(TSX TSX Toronto Stock Exchange (TSE before April, 2002)
TSX Transfer from Stack Pointer to Index
TSX True Space Extension
:BVF) today announced that the Company will present at the Scotia Capital Spring Growth Conference at the Loews Vogue Hotel in Montreal.

Biovail's presentation is scheduled for Thursday, March 29, 2007 at 10 a.m. EDT EDT
abbr.
Eastern Daylight Time


EDT Eastern Daylight Time

EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York

EDT 
. A live and archived Webcast, in addition to presentation slides, will be available on the Investor Relations page of Biovail's Web site at www.biovail.com.

About Biovail Corporation

Biovail Corporation is a specialty pharmaceutical company, engaged in the formulation, clinical testing, registration, manufacture and commercialization of pharmaceutical products utilizing advanced drug-delivery technologies. For more information about Biovail, visit the company's Web site at www.biovail.com.

For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to ir@biovail.com.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 23, 2007
Words:126
Previous Article:VCG Holding Corp. Announces Purchase Agreement to Acquire an Upscale Gentleman's Club in the Southeast.
Next Article:Odyssey Systems One of Five Awarded $350 Million TAASC Contract.
Topics:



Related Articles
Biovail Announces Public Offerings.
Biovail Announces Offering of US$275 Million Senior Subordinated Notes Due 2010.
Biovail Prices US$400 Million 7.875% Senior Subordinated Notes Due 2010.
Biovail Renews Revolving Term Credit Facility.
Biovail Renews Revolving Term Credit Facility.
Biovail to Present at the Merrill Lynch Canada 12th Annual Growth Stock Conference.
Biovail to Present at the Scotia Capital Pharmaceutical & Biotechnology Conference.
Biovail to Present at the JPMorgan Annual High Yield Conference 2007.
Biovail to Present at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference.
Biovail to Present at the Morgan Stanley Global Healthcare Unplugged Conference.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles